Literature DB >> 11580111

Hypertonic saline activation of p38 MAPK primes the PMN respiratory burst.

D J Ciesla1, E E Moore, W L Biffl, R J Gonzalez, H B Moore, C C Silliman.   

Abstract

Investigation of hypertonic saline (HTS) modulation of neutrophils (PMN) cytotoxic responses has generated seemingly contradictory results. Clinically relevant levels of HTS attenuate receptor-mediated p38 MAPK signaling, whereas higher levels activate p38 MAPK. Concurrently, HTS exerts a dose-dependent attenuation of the PMN respiratory burst, most notably at concentrations where p38 MAPK is activated. We hypothesized that HTS-mediated p38 MAPK activation augments the PMN respiratory burst on return to normotonicity. We found that although clinically relevant levels of HTS (Na+ > or = 200 mM) did not activate p38 MAPK, higher concentrations (Na+ > or = 300 mM) resulted in activation comparable with that after PAF stimulation. Transient stimulation with high levels of HTS primed the PMN respiratory burst in response to fMLP and PMA. This effect was attenuated by pretreatment with SB 203580, a p38 MAPK specific inhibitor. We conclude that severe osmotic shock primes the respiratory burst via p38 MAPK signaling, further supporting the role of this signaling cascade in PMN priming.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11580111     DOI: 10.1097/00024382-200116040-00009

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  10 in total

1.  Selective inhibition of polymorphonuclear neutrophils by resuscitative concentration of hypertonic saline.

Authors:  S H Choi; S W Lee; Y S Hong; J M Jeun; B W Min
Journal:  Emerg Med J       Date:  2006-02       Impact factor: 2.740

Review 2.  Postinjury Inflammation and Organ Dysfunction.

Authors:  Angela Sauaia; Frederick A Moore; Ernest E Moore
Journal:  Crit Care Clin       Date:  2017-01       Impact factor: 3.598

3.  Mechanism and effect of thrombospondin-4 polymorphisms on neutrophil function.

Authors:  Elzbieta Pluskota; Olga I Stenina; Irene Krukovets; Dorota Szpak; Eric J Topol; Edward F Plow
Journal:  Blood       Date:  2005-08-11       Impact factor: 22.113

Review 4.  Hypertonic saline: a clinical review.

Authors:  R Tyagi; K Donaldson; C M Loftus; J Jallo
Journal:  Neurosurg Rev       Date:  2007-06-16       Impact factor: 3.042

5.  Hypertonic saline enhances host response to bacterial challenge by augmenting receptor-independent neutrophil intracellular superoxide formation.

Authors:  Conor J Shields; Adrian W O'Sullivan; Jiang H Wang; Desmond C Winter; William O Kirwan; H Paul Redmond
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

6.  Hyperosmolarity attenuates TNF-α-mediated proinflammatory activation of human pulmonary microvascular endothelial cells.

Authors:  Anirban Banerjee; Ernest E Moore; Nathan J McLaughlin; Luis Lee; Wilbert L Jones; Jeffrey L Johnson; Trevor L Nydam; Christopher C Silliman
Journal:  Shock       Date:  2013-04       Impact factor: 3.454

7.  Hypertonic saline and reduced peroxynitrite formation in experimental pancreatitis.

Authors:  Ester Correia Sarmento Rios; Ana Soares Moretti; Irineu Tadeu Velasco; Heraldo Possolo de Souza; Fatima Abatepaulo; Francisco Soriano
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

8.  Small volume of hypertonic saline as the initial fluid replacement in experimental hypodynamic sepsis.

Authors:  Alejandra del Pilar Gallardo Garrido; Ruy Jorge Cruz; Luiz Francisco Poli de Figueiredo; Maurício Rocha e Silva
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 9.  Clinical review: Hypertonic saline resuscitation in sepsis.

Authors:  Roselaine P Oliveira; Irineu Velasco; Francisco Garcia Soriano; Gilberto Friedman
Journal:  Crit Care       Date:  2002-08-06       Impact factor: 9.097

10.  Hypertonic saline alleviates cerebral edema by inhibiting microglia-derived TNF-α and IL-1β-induced Na-K-Cl Cotransporter up-regulation.

Authors:  Lin-Qiang Huang; Gao-Feng Zhu; Yi-Yu Deng; Wen-Qiang Jiang; Ming Fang; Chun-Bo Chen; Wei Cao; Miao-Yun Wen; Yong-Li Han; Hong-Ke Zeng
Journal:  J Neuroinflammation       Date:  2014-06-11       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.